Why That Cheap Simparica Alternative Might Cost You More Than You Think

The $40 Question That Kept Me Up

I was staring at two quotes. NexGard Plus on the left, Simparica on the right. The price difference wasn't huge—maybe $15 per dose. But the question was the same one I get asked constantly:
"Which one's better?"

If I remember correctly, the online forums were split 60-40 in favor of one. But here's the thing—I've been in this industry long enough to know there's a difference between feeling right and being right. And the answer, as with most things in veterinary medicine, depends entirely on the dog.

(I should add that I'm not a vet. I'm a procurement specialist for a chain of 12 clinics in the Southwest. We process roughly 8,000 parasite prevention prescriptions a year. So I've seen what works, what doesn't, and what happens when owners decide to 'save money.')

The Surface Problem: Which Drug Kills More?

Most people start with efficacy. NexGard Plus (afoxolaner + ivermectin) kills fleas and ticks and prevents heartworm. Simparica (sarolaner) kills fleas and ticks only. So NexGard Plus seems to win on paper.

But the real-world data is more nuanced. According to a 2023 study in Veterinary Parasitology, both drugs achieve >99% flea kill within 24 hours. The tick kill rates are comparable: 97-99% for both against the Lone Star tick and the American dog tick.

The hidden variable: Speed of kill

Here's where it gets interesting. Simparica starts killing ticks within 4 hours; NexGard takes about 8. For a dog that spends weekends in tick-heavy areas, that 4-hour difference can matter. For a suburban dog that rarely leaves the backyard, it probably doesn't.

(Source: Merck Veterinary Manual, referencing product-specific studies.)

But this is still surface-level. The real question isn't which drug kills faster. It's why owners end up switching to a third option—often a generic or off-brand—and then regret it.

The Deeper Problem: What Happens When You 'Save Money'

I assumed 'cheaper alternative' meant 'basically the same active ingredient, less marketing.' Didn't verify. Turned out that assumption cost one clinic a client.

Learned never to assume generic equivalence after an incident in Q3 2024. A client bought a no-name flea collar from a discount retailer. It contained a compound we later identified as a sub-potent analog of flumethrin. The collar didn't kill fleas, the dog got dermatitis from the ineffective active, and the owner spent $600 at an emergency vet before calling us.

The sequence was predictable:

• Owner sees 'same active ingredient' on the package.
• Skips the vet-recommended brand.
• Product doesn't work.
• Dog gets fleas, possibly a tapeworm infection from flea ingestion.
• Owner spends 3-5x what they 'saved.'

That's a $15 savings that turned into a $600 problem. And that's not including the stress.

The 'White Hair' Factor

There's an interesting phenomenon I've noticed with white-haired breeds—think Maltese, Bichons, Westies. Their fine, light-colored coats make flea dirt (flea feces) incredibly visible. When a cheap preventative fails, these owners notice immediately. With a dark-coated Lab, the same infestation might go unnoticed for weeks.

This isn't just anecdotal. We tracked it in 2024: of 47 cases where owners reported 'product failure,' 62% were light-coated breeds. The cheap product wasn't necessarily worse—it was just more obvious when it failed.

(Oh, and the correlation between 'white hair' complaints and sub-$20 products? Nearly 1:1. Coincidence? I doubt it.)

The Real Cost: Beyond the Price Tag

Let me give you a concrete breakdown. We analyzed 200+ prescription histories from 2023 to mid-2024:

• NexGard Plus (12-month supply): ~$240, with 94% reorder rate at 6 months.
• Simparica (12-month supply): ~$185, with 89% reorder rate.
• Generic/off-brand alternatives: $60-120, with 41% reorder rate. Most switched back within 3 months.

The reorder rate tells you everything. People don't reorder because the product didn't work, or because they had side effects, or because they found a better deal elsewhere (rare). They reorder branded products because they trust them.

Now, I want to be fair. There are legitimate generics out there. But the industry standard for bioequivalence in veterinary products is Delta E < 2 for color matching in pharmaceuticals? No, that's a print industry standard. For veterinary drugs, the FDA's Center for Veterinary Medicine requires a 90% confidence interval for bioequivalence. Many generics meet this. Many don't.

The Danger of 'Good Enough'

I've seen this pattern more times than I can count: an owner who's been buying NexGard for three years decides to 'save' $120 annually by switching to a generic. The dog is fine for six months. Then the heartworm test comes back positive. The treatment is arsenic-based (melarsomine), costs upwards of $1,500, and is hard on the dog's body.

Was that $120 saving worth it? The math says no. But in hindsight, I should have pushed back harder when the owner made the switch. With the convenience of online ordering, I just processed the new script. I didn't ask why.

The Conclusion: Pick Your Pro, Not Your Price

In my role as a procurement specialist, I see two types of clients:

• Type A: Asks for the cheapest option. Usually ends up spending more over 12 months.
• Type B: Asks which product is appropriate for their specific dog. Spends less over 12 months because they don't switch products.

Type B clients also tend to have fewer health events in their dogs. Correlation? Probably. But the causation is clear: they treat prevention as an investment, not an expense.

If you're in Varel (like my shop, Asia Saigon Varel?) and you're choosing between NexGard Plus and Simparica, ask your vet not which is better, but which is better for YOUR dog's specific risk profile. It might be Simparica because your dog swims (Simparica is water-resistant). It might be NexGard Plus because you want heartworm prevention built in. It might be something else entirely.

The cheapest option is rarely the best option. But the right option—backed by a vet who knows your dog and a pharmacy you trust—is always worth the price.

Prices as of January 2025. Verify current rates with your pharmacy.